ENANTA PHARMACEUTICALS, INC (ENTA)

13.60 -1.45% (-0.20)

Over 5Y: -74.5%

2026-08-28
50 100
2021 2022 2023 2024 2025 2026

Financials Quarterly

Q4 '23 — Revenue: 18.9M Q4 '23 — Operating Cash Flow: -21.6M Q4 '23 — Free Cash Flow: -23M Q4 '23 — Net Income: -28.1M Q1 '24 — Revenue: 18M Q1 '24 — Operating Cash Flow: -25M Q1 '24 — Free Cash Flow: -25.8M Q1 '24 — Net Income: -33.4M Q2 '24 — Revenue: 17.1M Q2 '24 — Operating Cash Flow: -28.6M Q2 '24 — Free Cash Flow: -30.3M Q2 '24 — Net Income: -31.2M Q3 '24 — Revenue: 18M Q3 '24 — Operating Cash Flow: -14.8M Q3 '24 — Free Cash Flow: -21.3M Q3 '24 — Net Income: -22.7M Q4 '24 — Revenue: 14.6M Q4 '24 — Operating Cash Flow: -10.4M Q4 '24 — Free Cash Flow: -19.4M Q4 '24 — Net Income: -28.8M Q1 '25 — Revenue: 17M Q1 '25 — Operating Cash Flow: -16.8M Q1 '25 — Free Cash Flow: -25.5M Q1 '25 — Net Income: -22.3M Q2 '25 — Revenue: 14.9M Q2 '25 — Operating Cash Flow: -13.5M Q2 '25 — Free Cash Flow: -16M Q2 '25 — Net Income: -22.6M Q3 '25 — Revenue: 18.3M Q3 '25 — Operating Cash Flow: 17.5M Q3 '25 — Free Cash Flow: 17.4M Q3 '25 — Net Income: -18.3M Q4 '25 — Revenue: 15.1M Q4 '25 — Operating Cash Flow: -6.5M Q4 '25 — Free Cash Flow: -7.9M Q4 '25 — Net Income: -18.7M Q1 '26 — Revenue: 18.6M Q1 '26 — Operating Cash Flow: -11.7M Q1 '26 — Free Cash Flow: -11.8M Q1 '26 — Net Income: -11.9M Q2 '26 — Revenue: 17.2M Q2 '26 — Operating Cash Flow: -7.2M Q2 '26 — Free Cash Flow: -7.2M Q2 '26 — Net Income: -13.1M Q3 '26 — Revenue: 14.4M Q3 '26 — Operating Cash Flow: -10M Q3 '26 — Free Cash Flow: -10M Q3 '26 — Net Income: -19.5M -30M -15M 0 15M 30M
Q1 '24 Q3 '24 Q1 '25 Q3 '25 Q1 '26 Q3 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.8
SBC / sales 23.4%
OE margin -80.0%
Oper. margin -90.0%
Accruals -9.4%
EBITDA margin -82.5%
FCF margin -56.6%
OCF margin -54.1%
Profit margin -96.9%
ROA -21.3%
ROCE -24.2%
ROE -62.6%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 3.8×
Cash runway 5.1 yr
F-score 3.9 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales/sh Y/Y -0.15%
Shares change +0.85%
Sales Q/Q -21.6%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.